Picture of Orexo AB logo

ORX Orexo AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Orexo Q2 EBITDA Loss Widens To SEK 41.1 Mln

July 15 (Reuters) - Orexo AB  ORX.ST :
    * OREXO Q2 2021 INTERIM REPORT
    * Q2 TOTAL NET REVENUES OF SEK 142.8 M (179.1)
    * Q2 EBITDA OF SEK -41.1 M (-9.0)
    * Q2 NET EARNINGS OF SEK -73.7 M (-32.5)
    * Q2 OF 2021 SHOWED SOME POSITIVE OPERATIONAL HIGHLIGHTS IN
BOTH
OUR DIGITAL THERAPEUTICS (DTX) BUSINESS AND US PHARMA

Source text for Eikon:  ID:nWkr9kwbhg 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Orexo AB

See all news